{"id":"NCT01694186","sponsor":"EyePoint Pharmaceuticals, Inc.","briefTitle":"Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert","officialTitle":"A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08-02","primaryCompletion":"2018-03-26","completion":"2018-03-26","firstPosted":"2012-09-27","resultsPosted":"2020-03-23","lastUpdate":"2021-04-02"},"enrollment":129,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Non-Infectious Uveitis"],"interventions":[{"type":"DRUG","name":"FAI insert","otherNames":["Active Drug"]},{"type":"DRUG","name":"Sham injection","otherNames":["Sham Comparator"]}],"arms":[{"label":"sham injection","type":"SHAM_COMPARATOR"},{"label":"FAI insert","type":"EXPERIMENTAL"}],"summary":"A study to evaluate the safety and efficacy of an FAI insert for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye.","primaryOutcome":{"measure":"Proportion of Subjects With Recurrence of Uveitis in the Study Eye and Overall Summary of Number of Participants With Ocular Treatment-Emergent Adverse Events for the Study Eye Through Month 36 Visit","timeFrame":"36 months","effectByArm":[{"arm":"Sham Injection","deltaMin":12,"sd":null},{"arm":"FAI Insert","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":31},"locations":{"siteCount":34,"countries":["United States","Germany","Hungary","India","Israel","United Kingdom"]},"refs":{"pmids":["32624244"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":42},"commonTop":["Uveitis","Intraocular pressure increased","Cataract","Cystoid macular oedema","Macular oedema"]}}